Sabra Health Care REIT, Inc.
- Stock
- Ticker SBRA
- Nasdaq
Performance, volatility and drawdowns of Sabra Health Care REIT, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $20,957. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −74.9% in 03/2020, measured from the peak in 10/2019. It took 57 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 182 | 184 | 189 | 190 | 212 | 222 | 236 | 250 |
| Net income | 47 | 40 | 66 | 23 | 27 | 41 | -25 | 29 |
| Earnings per share | 0.20 | 0.17 | 0.27 | 0.09 | 0.11 | 0.16 | -0.10 | 0.11 |
| Balance sheet | ||||||||
| Total assets | 5,304 | 5,233 | 5,328 | 5,565 | 5,493 | 5,591 | 5,513 | 5,430 |
| Liabilities | 2,562 | 2,531 | 2,617 | 2,738 | 2,670 | 2,803 | 2,760 | 2,589 |
| Equity | 2,741 | 2,702 | 2,711 | 2,825 | 2,822 | 2,786 | 2,751 | 2,840 |
| Cash | 60 | 23 | 95 | 201 | 72 | 117 | 232 | 36 |
| Long-term debt | 2,418 | 2,394 | 2,480 | 2,591 | 2,529 | 2,665 | 2,626 | 2,436 |
| Cash flow | ||||||||
| Operating cash flow | 80 | 80 | 81 | 100 | 87 | 98 | 86 | 129 |
| Free cash flow | 80 | 80 | 81 | 100 | 87 | 98 | 86 | 129 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +41.1%, weakest 2017 at −16.9%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | $0.11 |
| 3 Aug 2026 | −$0.10 |
| 29 Apr 2026 | $0.16 |
| 12 Feb 2026 | $0.11 |
| 5 Nov 2025 | $0.09 |
| 4 Aug 2025 | $0.27 |
| 5 May 2025 | $0.17 |
| 19 Feb 2025 | $0.20 |
| 31 Oct 2024 | $0.13 |
| 7 Aug 2024 | $0.10 |
| 8 May 2024 | $0.11 |
| 27 Feb 2024 | $0.07 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €4.8bn
- Market cap in trading currency
- $5.34bn
- Enterprise value
- $7.74bn
- P/E
- 72.8
- P/S
- 5.81
- P/B
- 1.88
- EV/Sales
- 8.42
- EV/EBITDA
- 19.0
- Earnings yield
- 1.4%
- FCF yield
- 7.5%
Results (last four quarters)
- Revenue
- $919m
- Gross profit
- –
- EBITDA
- $407m
- Net income
- $71.5m
- Earnings per share
- $0.28
- Revenue per share
- $3.51
- Revenue growth
- +31.3%
- Earnings growth
- +26.9%
Profitability
- Gross margin
- –
- Operating margin
- 19.7%
- Net margin
- 7.8%
- Return on equity
- 2.5%
- Return on assets
- 1.3%
Balance sheet and cash flow
- Cash
- $36.2m
- Cash per share
- $0.14
- Financial debt
- $2.44bn
- Debt/equity %
- 86
- Current ratio
- –
- Book value per share
- $10.84
- Operating cash flow
- $401m
- Free cash flow
- $401m
Dividend
- Dividend yield
- 7.36%
- Dividend (12 months)
- $1.50
- Yield (12 months)
- 7.36%
- Payout ratio
- 536%
- Ex-dividend date
- 13 Nov 2026
Shares and trading
- Shares outstanding
- 262m
- Volume
- 3.25m
- Avg. volume 3 months
- 2.47m
- Relative volume
- 1.3
Price and technicals
- Price
- $20.39
- 1 day
- −0.3%
- 52-week high
- $22.39
- 52-week low
- $17.67
- Distance to 52-week high
- −8.9%
- Distance to 52-week low
- +15.4%
- Distance to 50-day line
- +2.7%
- Distance to 200-day line
- +1.4%
- RSI (14)
- 52
- Volatility 1M
- 26.5%
Performance
- 1 week
- −0.2%
- 1 month
- +4.0%
- 3 months
- −0.4%
- 6 months
- −1.6%
- YTD
- +7.7%
- 1 year
- +9.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has SBRA performed since 11/2016?
$10,000 grew to $20,957 by 20 Nov 2026, which is +7.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is SBRA?
Volatility was 30.0% per year, measured on monthly returns. The largest decline from a peak was −74.9%, with the low in 03/2020.
How does SBRA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, SBRA returned +7.7% at 30.0%. The correlation of monthly returns was 0.54; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.